Join
Live feed
·
INSIDERFilingvia Quantisnow
Twist Bioscience Corporation logo

Chief Executive Officer Leproust Emily M. sold $6,317,760 worth of shares (41,570 units at $151.98) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 770,729 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TWST (Twist Bioscience Corporation) and more on Quantisnow.